• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Select Medical Holdings Corporation (Amendment)

    2/2/24 5:19:23 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care
    Get the next $SEM alert in real time by email
    SC 13G/A 1 tm244929d2_sc13ga.htm SC 13G/A

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    SCHEDULE 13G

    (Rule 13d-102)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT 

    TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED 

    PURSUANT TO RULE 13d-2

    (Amendment No. 13)*

     

    Select Medical Holdings Corporation

    (Name of Issuer)

     

    Common Stock

    (Title of Class of Securities)

     

    81619Q105

    (CUSIP Number)

     

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨Rule 13d-1(b)
    ¨Rule 13d-1(c)
    xRule 13d-1(d)

     

     

     

    *   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior coverage page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No. 81619Q105

     

    1. NAMES OF REPORTING PERSONS
     
    Rocco A. Ortenzio
     
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)
    (b)
    ¨
    ¨
    3. SEC USE ONLY
     
     
    4. CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
     
    5.
     
    SOLE VOTING POWER
     
    3,975,550
     
     
    6.
     
    SHARED VOTING POWER
     
    3,814,8051
     
     
    7.
     
    SOLE DISPOSITIVE POWER
     
    3,975,550
     
     
    8.
     
    SHARED DISPOSITIVE POWER
     
    3,814,8051
     

    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    7,790,3551

     
    10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
    ¨
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
     
    6.07%1

     
    12. TYPE OF REPORTING PERSON

    IN

     

     

     

     

    1 Includes 10,000 shares of common stock owned by the reporting person’s spouse, as to which beneficial ownership is disclaimed.

     

     

     

     

    Item 1(a).Name of Issuer:

     

    Select Medical Holdings Corporation

     

    Item 1(b).Address of Issuer’s Principal Executive Offices:

     

    4714 Gettysburg Road, P.O. Box 2034, Mechanicsburg, Pennsylvania 17055

     

    Item 2(a).Name of Person Filing:

     

    Rocco A. Ortenzio

     

    Item 2(b).Address of Principal Business Office or, if None, Residence:

     

    c/o Select Medical Holdings Corporation 

    4714 Gettysburg Road, P.O. Box 2034, Mechanicsburg, Pennsylvania 17055

     

    Item 2(c).Citizenship:

     

    United States

     

    Item 2(d).Title of Class of Securities:

     

    Common Stock, $.001 par value (“Common Stock”)

     

    Item 2(e)CUSIP Number:

     

    81619Q105

     

    Item 3.If this Statement is Filed Pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a: Not Applicable.

     

    (a) ¨Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);

     

    (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

     

    (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

     

    (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

     

    (e) ¨ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

     

    (f) ¨ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

     

    (g) ¨ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

     

    (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

    (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);

     

     

     

     

    (j) ¨ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);

     

    (k) ¨ Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

     

    If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:_______________

     

    Item 4.Ownership.

     

    The following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1 is presented as of February 1, 2024:

      

    (a)Amount beneficially owned:

    7,790,3551

     

    (b)Percent of class:

    6.07%1 based upon 128,361,492 shares of Common Stock outstanding as of February 1, 2024.

     

    (c)Number of shares as to which such person has:

     

      (i) Sole power to vote or to direct the vote
         
        3,975,550
         
      (ii) Shared power to vote or to direct the vote
         
        3,814,8051
         
      (iii) Sole power to dispose or to direct the disposition of
         
        3,975,550
         
      (iv) Shared power to dispose or to direct the disposition of
         
        3,814,8051

      

    Item 5.Ownership of Five Percent or Less of a Class.

     

    Not Applicable.

     

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

     

    Not Applicable.

     

    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

     

    Not Applicable.

     

     

     

    1 Includes 10,000 shares of common stock owned by the reporting person’s spouse, as to which beneficial ownership is disclaimed.

     

     

     

     

    Item 8.Identification and Classification of Members of the Group.

     

    Not Applicable.

     

    Item 9.Notice of Dissolution of Group.

     

    Not Applicable.

     

    Item 10.Certifications.

     

    Not applicable.

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

      February 2, 2024
      Date
       
      /s/ Rocco A. Ortenzio
      Signature
       
      Rocco A. Ortenzio
      Name/Title

     

     

    Get the next $SEM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SEM

    DatePrice TargetRatingAnalyst
    4/16/2025$25.00Outperform
    Mizuho
    2/24/2025$23.00Hold → Buy
    The Benchmark Company
    11/25/2024Buy → Hold
    The Benchmark Company
    8/20/2024$42.00Buy
    BofA Securities
    3/7/2022$47.00 → $42.00Outperform
    RBC Capital
    1/18/2022$40.00 → $35.00Buy
    B of A Securities
    1/18/2022$50.00 → $47.00Outperform
    RBC Capital
    8/10/2021$37.00 → $39.00Neutral
    Credit Suisse
    More analyst ratings